首页> 美国卫生研究院文献>World Journal of Hepatology >Primary mucosa-associated lymphoid tissue lymphoma of the liver: A report of two cases and review of the literature
【2h】

Primary mucosa-associated lymphoid tissue lymphoma of the liver: A report of two cases and review of the literature

机译:肝原发性黏膜相关淋巴组织淋巴瘤:两例报道并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mucosa-associated lymphoid tissue (MALT) lymphoma of the liver is a very rare condition and thus the diagnosis may be challenging. The clinical presentation is usually variable, ranging from minimal clinical symptoms to severe end stage liver disease. In this paper, we describe the clinicopathologic findings in two cases of primary hepatic MALT lymphoma. One case is an 80-year-old female with no underlying chronic liver disease and the second case is a 30-year-old female with autoimmune hepatitis complicated by MALT lymphoma. In both specimens, there was diffuse infiltration of atypical B-lymphocytes that were positive for CD20 and CD79a, but negative for CD5, CD43 and CD10. There were occasional lymphoepithelial lesions involving the hepatocytes or bile ducts. Polymerase chain reaction analysis showed monoclonal immunoglobulin heavy chain gene rearrangement in both cases. The first case was treated with surgery but developed pulmonary recurrence a year after complete resection but went into remission following treatment with rituximab. A second recurrence occurred in the right parotid gland 7 years later, which was treated with idelalisib. The second case was effectively treated with rituximab. To our knowledge, the second case is the first reported case linked to autoimmune hepatitis.
机译:肝的粘膜相关淋巴样组织(MALT)淋巴瘤是非常罕见的疾病,因此诊断可能具有挑战性。临床表现通常是可变的,范围从最小的临床症状到严重的末期肝病。在本文中,我们描述了2例原发性肝MALT淋巴瘤的临床病理发现。一例是80岁的女性,没有潜在的慢性肝病;第二例是30岁的女性,患有自身免疫性肝炎并伴有MALT淋巴瘤。在两个标本中,都有非典型B淋巴细胞的弥漫性浸润,其中CD20和CD79a呈阳性,而CD5,CD43和CD10呈阴性。偶有淋巴上皮病变累及肝细胞或胆管。聚合酶链反应分析显示在两种情况下单克隆免疫球蛋白重链基因重排。第一例接受手术治疗,但在完全切除一年后出现肺部复发,但接受利妥昔单抗治疗后缓解。 7年后右腮腺再次发生复发,用艾得利西布治疗。第二例用利妥昔单抗有效治疗。据我们所知,第二例是与自身免疫性肝炎有关的第一例报道病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号